INTRODUCTION
============

Over the decades, world population tremendously increased to 7 billion ([@B35]) and 870 million (12.5%) of them were estimated to be undernourished during 2010--2012 ([@B35]; [@B75]). Demand for animal source food tends to be soaring day by day, especially in developing countries ([@B34]; [@B75]). It is acknowledged that the antimicrobial use is one of the most successful chemotherapies. Various antimicrobials have made significant contribution for the prevention, control, and treatment of infectious diseases in animals since 1940s ([@B39]). Low and sub-therapeutic dose of antimicrobials plays very important role for the improvement of feed efficiency, promotion of animal growth, and prevention and control of the diseases ([@B24]; [@B95]). International market value of veterinary drugs (including antimicrobials) tremendously increased from \$8.65 billion in 1992 to \$20.1 billion in 2010 and in 2018, it is expected to increase to \$42.9 billion ([@B44]; [@B105]).

It is undeniable that rational use of antimicrobials plays a vital role in the production of food animals and protecting public health, while irrational and irresponsible use may cause antimicrobial resistance. On the basis of "Swan Reports" in 1969, Great British took first action for the restriction of antibiotics, being used in animals or capable of cross-resisting with antibiotics used in human medicine. In 1973, the European Community (EC) commenced the withdrawal of some important antibiotic use as growth promoters in animal feed. After that, Sweden banned the use of all growth-promoting antibiotics in 1986. Avoparcin, bacitracin, spiramycin, tylosin, and virginiamycin were withdrawn as growth promoters in the European Union (EU) from 1995 to 1999, on the basis of precautionary principle. In 2006, all the uses of low-dose antibiotics (5\~40 ppm) in food animals, including flavomycin, avilamycin, salinomycin, monensin, and other animal-specific antibiotics, were banned in the EU with the intention to avoid their negative impact of resistant development ([@B31]; [@B85]).

The benefits and risks of antimicrobials continue to be complex and controversial issues. The risks of antimicrobial drugs to public health associated with antimicrobial resistance raised great concern recently, while the benefits of antimicrobial drugs, such as prevention and treatment of animal diseases, protection of public health, enhancement of animal production, and improvement of environment, were disregarded most of the time. Many benefit-related claims have not yet been fully demonstrated in large-scale trials, and other trials revealed that the overall impact of the short-term benefits was poorly described. This article presents the benefits and risks of antimicrobials drugs used in food animals and discusses the positive and negative effects of the ban on antimicrobial growth promoters.

BENEFITS OF ANTIMICROBIAL DRUGS
===============================

PREVENTION AND TREATMENT OF ANIMAL DISEASES
-------------------------------------------

With intensive animal production, bacterial and parasitic diseases became more and more frequent. According to an estimate, 80 types of bacteria, such as *Escherichia coli*, *Salmonella*, and *Clostridium welchii*, posed a serious threat to poultry industry. Mastitis, caused by *Staphylococcus aureus* in dairy animals, led to a loss of \$2 billion/year in the United States of America (USA) and an average cost of €485/dairy cow in the EU during 2012 ([@B53]). Due to infection caused by *Streptococcus pneumonia*, morbidity and mortality rates in calves increased to 40 and 20%, respectively ([@B1]; [@B127]). More than 50% of aquatic animals were infected by bacteria each year ([@B112]). *Vibrio vulnificus* became a potential health hazard for aquatic animals and human beings ([@B132]).

Approximately, 2169 parasites including 203 protozoa, 373 trematodes, 150 tapeworms, 404 nematodes, and 1030 arthropods have been found in livestock and poultry in China. About 4--20 billion dollars/year (8.3% annual output of animal husbandry) were lost due to parasitic diseases caused by coccidia, nematodes, ticks, and others in USA ([@B74]). Acute outbreaks of chicken coccidiosis paid a loss of 42 million pounds annually in the United Kingdom ([@B10]). In China, poultry industry had to face billions of dollars annual loss due to almost 100% chicken morbidity by coccidiosis ([@B133]). Sheep helminthiasis led to a loss of 2.22 million dollars annually in Australia ([@B59]; [@B77]).

Over one hundred of antimicrobials, including β-lactams, aminoglycosides, tetracyclines, amphenicols, macrolides, sulfonamides, fluoroquinolones, lincosamides, polypeptides, and polyene, have been used in food-producing animals around the world. These antimicrobials have played an essential role in the prevention, treatment, and control of food animal diseases caused by pathogens, such as pathogenic *E. coli*, *S. aureus*, *S. pneumonia*, *Actinobacillus pleuropneumoniae*, mycoplasma, *Vibrio*, and others ([@B57]; [@B74]). It was reported that in USA, 52.1% of total antimicrobials were used for the treatment of infectious diseases in animals, where 90% of starter pigs, 75% of grower pigs, 50% of finisher pigs, and 25\~70% of cattle received the drugs through feed ([@B121]; [@B120]; [@B45]). With a dose of 40 mg/kg, avilamycin in feed could remarkably decrease the incidence of diarrhea in post-weaning pigs ([@B99]). When salinomycin was used in sows and pigs simultaneously, incidence of diarrhea in piglets was significantly reduced and the survival rate was increased by 13.95% ([@B92]). Sulfonamide and folic acid supplementation in diet increased live birth rate of piglets by 1% ([@B78]). Hence, it is concluded that the use of antimicrobials is a primary strategy for prevention and treatment of bacterial infections in food-producing animals.

Many antimicrobials have strong activity against parasites in animals. Use of sulfonamides in animals opened a new era of anti-parasitic drugs and made lots of parasitic diseases under control. Up till now, anti-parasitic drugs have shared about one-third sale of the global veterinary drug markets. Macrolides and benzimidazoles effectively controlled nematodes. Doramectin and ivermectin helped to prevent infection of *Argulus siamensis* in carp and *Labeo rohita* ([@B54]). In rabbit, subcutaneous injection of ivermectin, at dose of 400 mg per kg, not only helped to clinical cure ear mite infection but also prevented loss of fur and thus, played a vital role for the improvement of fur production ([@B86]).

Conclusively, due to unique advantages, such as exact targeting of pathogens, well-known mechanisms of activity and desired stability, antimicrobials justified their usage in livestock and poultry, and played important part for prevention and treatment of bacterial and parasite diseases.

PROTECTION OF HUMANS AGAINST ZOONOSIS
-------------------------------------

Among animal infectious and parasitic diseases, more than 200 can affect human life. *Campylobacter* spp., *Salmonella* spp., *E. coli* O157, *Vibrio parahaemolyticus*, and *Aeromonas hydrophila* from animals pose great health threat to both humans and animals ([@B6]; [@B89]). The United States Centers for Disease Control and Prevention (US-CDC) estimated that there were about 76 million annual cases of food-borne illness in USA, including 325,000 hospitalizations and 5000 deaths ([@B87]). Annual cases of *Campylobacter* spp., *Salmonella* spp., *E. coli* O157, and *V. parahaemolyticus* were 1,963,000, 1,332,000, 62,500, and 5000, respectively ([@B87], [@B88]).

To some extent, antimicrobial agents guaranteed human food security and public health by controlling animal diseases and preventing transmission of zoonotic pathogens from animals to humans. When added to animal feed or drinking water, these drugs could significantly decrease the bacterial contamination in animal products. For examples, virginiamycin decreased the contamination of *Clostridium perfringens*, *Campylobacter* spp., and other food-borne pathogens in animal carcasses ([@B118]; [@B110]; [@B62]). Salinomycin reduced infection of type C *Clostridium* in sows and weaning piglets by 43% ([@B92]). Neomycin in animal feed significantly reduced the number of *E. coli* O157: H7 in animal feces, and gentamycin reduced bacterial count in poultry eggs and meat ([@B29]; [@B27]). When cattle was fed with neomycin sulfate for 48 h and held for 24-h drug withdrawal period before slaughtering, it shed considerably less *E. coli* O157:H7 cells than those pen mates who did not receive the treatment ([@B29]). A farm-level study in 2008 by Ohio State University demonstrated that only 39% of hogs, raised on conventional antimicrobial operations, were infected with *Salmonella*, while those were 54% in case of antimicrobial-free operations ([@B97]; [@B7]). Florfenicol (10 mg/kg) presented 100% efficiency for the treatment of *A. hydrophila* of *Piaractus mesopotamicus* ([@B11]). Oxytetracycline hydrochloride or norfloxacin in bait feed reduced the number of *A. hydrophila* in water by 46.86\~66.24%, indicating that the risk of the bacterial infection to humans be decreased.

ENHANCEMENT OF ANIMAL PRODUCTION
--------------------------------

In 1943, a few farmers in USA found that pigs fed with penicillin-fermented mixture grew faster ([@B128]; [@B56]; [@B117]). In 1946, Moore found that low dose of streptomycin stimulated chick's growth ([@B91]; [@B24]). Subsequently, chlortetracycline, doxycycline, and sulfonamides helped growth promotion in calves, pigs, and chicken. Cunha from University of Florida and Stokstad from University of Washington reported that penicillin in fermentation mixture functioned as a growth promoter for food-animals ([@B22]). Legal use of the antimicrobials in feed has a history of over 60 years. Food and Drug Administration in USA (US FDA) approved these drugs as growth promoters for animals in 1951. Till 1978, 47.9% of the antimicrobials were used to be added in animal feed in USA. About 60% of poultry, 93% of chicken, 97% of growing pigs, and 80% of fattening pigs received antimicrobials through diet during the early 1990s. More than 40% of the drugs were added in animal feed at subtherapeutic level for improving animal production in USA during 1990s ([@B121]). With a substantial contribution to the development of food-animal production at global level, veterinary antimicrobials tend to be necessities to cope with increasing food demand for humans.

Role of antimicrobials for the improvement of feed conversion ratio (FCR), animal growth, and reproductive performance has been well proven as given in **Table [1](#T1){ref-type="table"}**, and discussed under following points ([@B17]). (1) Orally administered antimicrobials in pigs increased diet digestibility and improved feed utilization efficiency by 1.7\~5.1% and 6.9\~7%, respectively ([@B18]; [@B50]; [@B66]; [@B121]). (2) Addition of the drugs (e.g., chlortetracycline, sulfonamide, folic acid, carbadox, tilmicosin, tylosin, or sulfamethazine) in feed could remarkably improve the conception rate, farrowing rate, milk secretion, productive efficiency of sow, and live birth rate of piglet ([@B115]; [@B78]; [@B4]; [@B71]; [@B129]; [@B99]). (3) Feeding antimicrobials to pigs increased their weight gain by 1.9\~16.4% ([@B92]; [@B18]; [@B66]; [@B121]; [@B64]). (4) Administration of antibiotics (bacitracin zinc, colistin sulfate, flavomycin, and florfenicol) in fish diet significantly improved the feed conversion and promoted their growth ([@B52]; [@B134]). (5) Antimicrobial (tiamulin, nosiheptide, salinomycin, and tylosin) supplementation could also improve the carcass quality by decreasing the fat thickness and increasing the lean meat of food-producing animals ([@B20], [@B21]; [@B19]; [@B79]; [@B121]).

###### 

Part of evidences for the role of antimicrobials on feed utilization, growth promotion, reproductive performance, and carcass quality.

  Example no   Reference                       Drugs and animals                                                                                        Parameters of animal production   Increase or decrease rate   
  ------------ ------------------------------- -------------------------------------------------------------------------------------------------------- --------------------------------- --------------------------- --
  1            [@B50], [@B121]                 Antimicrobials to growing and fattening pigs                                                             Digestion of energy               5.10%↑                      
                                                                                                                                                        Digestion of nitrogen             1.80%↑                      
                                                                                                                                                        Digestion of phosphorus           3.40%↑                      
  2            [@B121]                         Antimicrobials to swine                                                                                  Feed utilization                  7%↑                         
                                                                                                                                                        Average weight gain               3.3--8.8%↑                  
  3            [@B66], [@B121]                 Antimicrobials to young pigs                                                                             Feed utilization                  4.60%↑                      
                                                                                                                                                        Average weight gain               6.80%↑                      
                                               Antimicrobials to grower pigs                                                                            Feed utilization                  1.70%↑                      
                                                                                                                                                        Average weight gain               1.90%↓                      
  4            [@B18], [@B121]                 Antimicrobials to piglet                                                                                 Feed utilization                  6.90%↑                      
  5            [@B64]                          Antimicrobials to food animal                                                                            Average weight gain               4--5%↑                      
  6            [@B18], [@B121]                 Antimicrobials to piglet                                                                                 Average weight gain               16.40%↑                     
  7            [@B92]                          Salinomycin to weanling piglets                                                                          Average weight gain               15.82%↑                     
  8            [@B52], [@B134]                 (Bacitracin zinc, colistin sulfate, Flavomycin and florfenicol) to (Carassius, Carp or hybrid tilapia)   Average weight gain               24.5\~40.87%↑               
  9            [@B115]                         Chlortetracycline to sow                                                                                 Conception rate                   4.10%↑                      
                                                                                                                                                        Farrowing rate                    5.80%↑                      
  10           [@B78]                          Folic acid to sow                                                                                        Gestation gain                    18%↑                        
  11           [@B19], [@B20], [@B1], [@B79]   Tiamulin, nosiheptide, and salinomycin to pig                                                            Thickness of backfat              9.7%↓                       
                                                                                                                                                        Thickness of total fat            8%↓                         
                                                                                                                                                        Eye muscle area                   9.80%↑                      
                                                                                                                                                        Lean meat                         4.40%↑                      

↑ Denotes increase, while ↓ denotes decrease.

A lot of studies were carried out to find the mechanism involved in beneficial aspects of antimicrobials in animals. Jukes, Franti, and other scientists proved that the drugs attenuated intestinal wall and improved the digestibility of nutrients ([@B84]; [@B32]; [@B69]; [@B40], [@B41]; [@B24]). [@B90] and [@B96] confirmed that oral doses of antimicrobials improved the structure of intestinal flora ([@B90]; [@B96]). Salinomycin and avilamycin in feed improved the bioavailability of α-tocopheryl acetate in broilers by altering lipid absorption ([@B72]). According to a previous review by [@B5], antimicrobials have multi-functional role in animals, elaborated under following points: (1) these could reduce the colonization of intestinal bacteria and inhibit the growth of pathogenic microorganisms; (2) by decreasing the thickness of mucous membrane, led to more absorption of nutrients and reduced fermentation; (3) they directly neutralized the host immune response. In short, antimicrobials could affect the host intestinal flora, intestinal physiology, and immune system, and consequently, prevent disease, improve feed conversion, and enhance the growth of animals ([@B95]). Till now, there are no appropriate alternatives which can replace antimicrobial growth promoters, in case those remain banned. Although numerous feed additives, mainly pre- and pro-biotic products, are commercially available now and seem to have potential to replace these growth promoters, but their true efficacy and mechanism of action in domestic animals remain unclear because of some inconsistent experimental results ([@B42]; [@B5]). Additionally, lack of safety evaluation and poor stability also limited the practical use of pre- and pro-biotic as feed additives.

IMPROVEMENT OF ENVIRONMENT
--------------------------

According to a report of [@B13]) and [@B33]), housing stress, due to over-crowding of animals, creates sweeping and devastating impacts on the natural and human environment leading to global warming, land degradation, air and water pollution, and loss of biodiversity. Livestock waste is one of the major sources of greenhouse gases, as the abnormal fermentation of gastrointestinal tract contents can produce lots of methane, ammonia, carbon dioxide, as well as stench gases (e.g., nitrate, ethylene acid, methyl mercaptan, hydrogen sulfide, methylamine, and trimethylamine). Fecal waste of animals generally contains 24% protein and 6.1\~17.96% amino acids. Nitrogen and phosphorus in the waste lead to environmental pollution, water eutrophication and ecological imbalance.

Some antimicrobials in feed could inhibit the abnormal fermentation and consequently, reduce the emission of greenhouse gases (mainly CH~4~). For example, ionophores (monensin, lasalocid, and salinomycin), amoxicillin, ovoparcin, nigericin, or laidlomycin inhibited rumen microbial fermentation at different levels and thus, reduced the proportion of volatile fatty acids (VFA) and methane ([@B122]; [@B38]; [@B26]). Since the mid-1970s, ionophorous antibiotics have been widely used as feed additives in ruminants due to their favorable effects on rumen fermentation and methane reduction ([@B73]). Due to the efficacy and affordable price, ionophores have widely been used to reduce methane emission from livestock ([@B58]; [@B73]). When ionophores (monensin and lasalocid) were mixed with rumen microorganisms *in vitro*, these inhibited methane by 50 and 44%, respectively and decreased NH~3~ by more than 50% ([@B109]). In rumen models, ionophores (monensin, lasalocid, and salinomycin) inhibited 10\~20% lipolysis and biological hydrogenation ([@B123], [@B122]). The effects of the antibiotics on the abatement of methane production may be attributed to a selective antimicrobial action on rumen microbes (protozoa, ruminococci, streptococci, and lactobacilli). Addition of monensin and lasalocid in cow forage killed 82.5 and 76.8%, respectively, of the intestinal ciliated protozoa in rumen and hence, reduced the production of methane and VFAs (acetic acid and propionic acid) by ciliates ([@B46]). Generally, the gas production was reduced from 4 to 31% by monensin ([@B113]; [@B108]; [@B73]). A recent report has indicated that long-term administration of monensin in dairy cattle steadily reduced methane by 7% and this reduction persisted for 6 months with no adverse effect on milk yield ([@B98]). However, previous studies also found that both, the methane level and protozoal number, returned to baseline after long-term administration of high concentration of the antibiotic ([@B46]; [@B98]; [@B58]). The efficiency of monensin supplementation, for reducing methane output in ruminants, appeared to be different in the degree of abatement depending on the diet and animal used ([@B46]; [@B98]; [@B58]). Effect of the drug on the methane levels in rumen was closely related to the ciliated, protozoal population. Microbial consortia, like protozoal population, in the ruminant gut may adapt to the antibiotics leading to the recovery of methane production yield, in case of a long-term usage. Therefore, the ciliates in the rumen may impact the outcome of antimicrobial supplementation, with adaptation being a possibility ([@B46]; [@B58]).

Through manure application, antibiotics got released into soil and could be absorbed by plants in arable land. Certain species of plants have the ability to bio-accumulate sulfamethoxine in their roots and stems, and this bioaccumulation was often higher in roots than in stems ([@B111]). Low concentrations of chlortetracycline and oxytetracycline in the soil media could markedly affect plant growth and development ([@B111]). However, there was a large variation in sensitivity among plant species to the soil used as the growth media ([@B111]).

When residues seeped into water, certain antimicrobials also played significant role in the prevention of water eutrophication for aquatic animals. For example, chlortetracycline, lomefloxacin hydrochloride, and sulfamethoxazole strengthened the absorption of nitrogen and phosphorus in water by aquatic plants, and chlortetracycline effectively removed 25% of water nitrate and nitrogen ([@B25]; [@B67]). On the other hand, the presence of antibiotic residues in environment may cause some adverse impacts, like acute and chronic toxicity, during early life stages of different aquatic organisms ([@B48]; [@B111]).

NEGATIVE IMPACT OF ANTIMICROBIAL BAN
------------------------------------

Ban on addition of sub-therapeutic antimicrobials in feed appeared to result in a certain extent of recovery of some bacteria and some unintended impacts on animal health and welfare ([@B28]; [@B107]; [@B82]; [@B65]). Emergence of *E. coli* and *Lawsonia intracellularis* infection in post-weaning pigs was significantly increased and consequently, the morbidity and mortality due to diarrhea were considerably increased ([@B12]; [@B24]). In Denmark, the mortality rate in weaning piglets increased from 2.7% (before the ban) to 3.5% (after the ban) and the morbidity rate of enteric infections in post-weaning pigs increased by 600% ([@B12]; [@B24]). In Sweden, chronic infections due to *E. coli* and *L. intracellularis* became more common and the mortality in weaning pigs increased by 1.5% ([@B131]; [@B12]).

To control animal diseases and to keep animals healthy, more therapeutic antimicrobials had to be used after the ban. It was reported that the usage amount of therapeutic antimicrobials in Denmark increased by 33.6%, from 48 tons/year in 2001 to 125.5 tons/year in 2010 ([@B23]). The increased amount of therapeutic antimicrobials was equal to or even more than the total quantity of antimicrobials being used before the ban ([@B100]; [@B12]; [@B102], [@B103]; [@B119]; [@B23]). As shown in **Figure [1](#F1){ref-type="fig"}**, therapeutic use of tetracycline, penicillins, and macrolides markedly increased from 28.5, 16.4, and 13.4 tons in 2001 to 35.55, 27.1, and 16.8 tons in 2010, respectively ([@B101]; [@B23]).
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Withdrawal of low-dose antimicrobial use as feed additives may increase the level of pathogens such as *Salmonella* spp., *Campylobacter* spp., *Clostridium* and *E. coli* O157 in animal gut, boost the contamination of food and environment, and hence, enhance the opportunities for humans to be infected by these pathogens. Population of *Campylobacter* in broilers fed without antimicrobials was threefold higher than that in the broilers fed with any antimicrobials ([@B55]). Incidence of food-borne *Campylobacter* in EU has been increased after the ban issue. Recovery of *Clostridium* from animal meat was also significantly increased in EU after its ban policy ([@B68]; [@B104]). As a consequence, clostridial infections resulted in an outbreak affecting large human population in Demark and pointed out the high level of threat to public health ([@B23]). It is known that clostridial necrotic enteritis in animals is suppressed by some of the banned antimicrobials (e.g., virginiamycin). In the absence of these antibiotics, the bacterial population may increase in animal guts and colonization may lead to poor weight uniformity and fragile intestines in pigs and chicks. During food processing, infected animal carcasses could be the sources of contamination for food-borne pathogens and thereby, jeopardize food hygiene ([@B118]; [@B110]). Bacterial contamination of meat may, therefore, increase the risk of human infections. Contrary to EU, incidence of food-borne diseases in USA was declined by 23% in 1996 and among those, the infections due to *Campylobacter* and *Salmonella* were decreased by 30 and 17%, respectively. It was believed that ban of virginiamycin in USA might annually contribute to the death of 40,000 people, infected by *Campylobacter* ([@B16]).

The ban may lead to increased food-borne infections and elevated usage of therapeutic antimicrobials in both animals and humans. It is noteworthy that therapeutic use of antimicrobial agents in animals has a close relationship with the drugs used in humans with respect to the types of drugs used ([@B15]). The increased therapeutic use in animals may contribute to a worse, drug-resistance scenario both in animals and humans. It was noted that clinical isolates of vancomycin- or teicoplanin-resistant *Enterococci* from humans were very uncommon and the cases of quinupristin/dalfopristin-resistant *Enterococcus faecium* were very rare before the ban. Similarly, resistant *E. faecium* burden markedly increased and became a big challenge after the ban ([@B101]).

After the European ban on growth-promoting antibiotics, it was found that FCR (total kg of feed used per grow out/total kg of live weight per grow out) in broiler was decreased by 0.016 kg/kg from November 1995 to May 1999 (1.78--1.796) in Denmark. Feed efficiency raised to a higher value of 1.83 immediately after the restrictions and more than 1.84 in late 1999 ([@B30]; [@B24]). Average daily gain of weaning piglets in Denmark was decreased from 422 g in 1995 to 415 g in 2001 ([@B12]; [@B24]). Production of broilers, cattle, and dairy cows was significantly decreased in 2006, as shown in **Figure [2](#F2){ref-type="fig"}**. In Sweden, weight gain of post-weaning piglets was reduced and feed costs were significantly increased after the abolishment of growth-promoting antimicrobial agents ([@B131]; [@B12]). Even after 10 years, aquaculture production in Sweden was unable to return to the past level ([@B12]).
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If the use of antimicrobials is banned in USA, FCR may decline by 5% and more than 1100 km^2^ area is required to plant corn and soybeans to meet the demand of feedstuff production. Consequently, required facilities for livestock and poultry production will be correspondingly increased by 100 million m^2^, and farming area will also be increased by 500 million m^2^ to obtain the current level of animal production ([@B12]). It was estimated that withdrawal of antimicrobial growth promoters might lead to a loss of 5\~10 or even 40 dollars/pig in USA ([@B83]). It does not seem to be a high cost for the developed countries but what will be the consequences if these antimicrobials are banned worldwide? It was also investigated that 25% of the current poultry industry and \$3 billions would be additionally required to attain the current annual animal production ([@B106]; [@B64]). In conclusion, keeping in view the ever-increasing world population and its demands, more food animals should be raised to meet the food supply demand in the case of growth-promoting antibiotics remain prohibited and this increased number of animals will again lead to the increase in greenhouse gas emission and deeper environmental pollution.

RISKS OF ANTIMICROBIALS
=======================

INHIBITION OF BIOGAS PRODUCTION
-------------------------------

Following the wide use of antimicrobial drugs in intensive animal production for growth promotion and prevention or treatment of disease, a large proportion of ingested drugs are excreted in manure and end up with livestock wastewater. Excreted antibiotics in the environment may partially inhibit methanogenesis in anaerobic waste-storage facilities, commonly used at Concentrated Animal Feeding Operation (CAFOs), and thus, decrease the rate at which bacteria metabolize animal waste products ([@B80]; [@B111]).

During the anaerobic digestion of livestock waste, certain antimicrobials, including amoxicillin, aureomycin, oxytetracycline, thiamphenicol, florfenicol, sulfadimethoxine, and tylosin, had inhibitory effects on methane production ([@B76]; [@B116]; [@B114]; [@B8]). However, no inhibitory effect but a stimulus for methane production was observed during anaerobic digestion of piggery wastewater in the presence of 10 mg/L florfenicol, amoxicillin, aureomycin, and sulfadimethoxine, while only the combination of high concentration of certain antimicrobials (130 mg/L florfenicol, 210mg/L amoxicillin, 10mg/L doxycycline, and 210 mg/L sulfadimethoxine) could decrease the methane production rate ([@B116]). Biogas volume, produced from per unit weight of biomass, was decreased with increasing concentrations of antibiotics, such as oxytetracycline, amoxicillin, and tylosin, and the inhibitory concentrations of oxytetracycline, amoxicillin, and tylosin were 8000, 9000, and 9000 mg/L, respectively ([@B8]). Only high concentration of thiamphenicol (160 mg/L), amoxicillin (120 mg/L), tetracycline (50 mg/L), and sulfamethoxydiazine (50 mg/L) had inhibitory effect on biogas production in the anaerobic digestion of pig waste slurry ([@B76]; [@B114]). Actually, it is too difficult to attain those high concentrations of antibiotics in the excreta.

ANTIMICROBIAL RESISTANCE CONCERNS
---------------------------------

Misuse and overuse of antimicrobial may culminate in the development of drug-resistant pathogens resulting in poor response to treatment. Long-term and low-level exposure to antimicrobials may have greater selective potential than short-term and full-dose therapeutic use. A study observed that the percentage of tetracycline resistance genes in the fecal flora of conventionally raised feedlot steers was significantly higher than that in fecal samples from antimicrobial-free cattle ([@B51]). Additionally, use of single antimicrobial may induce cross-resistance to antimicrobials used for animal and human medical therapy. For example, chlortetracycline use in growth rations was associated with ampicillin and tetracycline resistance in generic fecal *E. coli*, isolated from swine farms ([@B124]). Addition of chlortetracycline and sulfamethazine in cattle feed may be associated with higher prevalence (three to four fold greater than the control) of ampicillin- and tetracycline-resistant *E. coli*, isolated from the feces of treated animals ([@B3]). Therefore, how to use antimicrobials, for effective treatment of bacterial and parasitic infections in food-producing animals, became the most important question for their use by avoiding the resistance development.

Regarding public health risk, more concern has been raised for the use of antibiotics in animals that may represent a potential threat to human health because the resistant pathogens in animals may transmit to humans and cause treatment failure of human medicines. A longitudinal study of the relationship between antimicrobial-resistant *E. coli* from human wastewater and swine fecal samples reported that the use of injectable (e.g., ceftiofur sodium) or oral (e.g., chlortetracycline) antibiotics may contribute to the high levels of *E. coli* resistance in swine and human isolates. Thus, slaughter plant workers may be at higher risk of carrying multidrug-resistant *E. coli* as compared to workers dealing with other animals ([@B2]). A study analyzed the correlation between *E. coli* isolates from human blood stream and food-producing animals (poultry, pigs, and cattle) for the prevalence of antimicrobial resistance in 11 countries during 2005--2008. Results revealed that there were strong and significant correlations between the strains from animals (especially poultry and pigs) and humans for resistance to multiple drugs (especially ampicillin, aminoglycoside, and fluoroquinolone; [@B126]). However, there is not enough and direct evidence to support the hypothesis that a large proportion of resistant isolates in humans be derived from animal source foods. Some recent studies suggested that some resistant isolates from humans were more easily transmitted from companion animals (having close contact) or birds (by bird droppings especially during their migration; [@B47]; [@B81]). The resistant bacteria may also be released into the environment by humans and then transferred into new hosts in the environment ([@B60]; [@B125]). Based on the results of some current studies, Dr. Hurt pointed out that public health risk due to infected animals need more attention than antibiotic resistance concern ([@B61], [@B63]). Therefore, further efforts are required for the risk assessment of antimicrobial use in food animals to check their potential impact on public health.

POSITIVE EFFECTS OF ANTIMICROBIAL BAN
-------------------------------------

Aim for the withdrawal of antimicrobial agents used was to prevent humans and animals from drug resistance. The ban on antimicrobial growth promoters led to decreased drug resistance in some bacteria. For example, according to report from the DANMAP, substantial reductions (from 80 to 2%) in the prevalence of vancomycin-resistant enterococci (VRE) were observed after ban of avoparcin as the growth promoter during 1995 and 2010 ([@B23]). *E. faecium* and *Enterococcus faecalis* are two of the most common *Enterococci* species and in Europe, only vancomycin-resistant *E. faecium* (VREF) is highly prevalent in poultry ([@B130]). VREF was still present as a threat in the food chain even after 15 years of the EU ban on avoparcin and could be detected in 47% of the broiler feces with a selective enrichment method ([@B43]; [@B23]).

The ban on tylosin as the growth promoter had a remarkable effect on the level of macrolide (erythromycin) resistance in *Campylobacter coli* (most common *Campylobacter* species in pigs) from pigs as it decreased from 66 to 20% in Denmark between 1998 and 2005 ([@B49]). However, DANMAP data showed that during 2006--2010, macrolide resistance in *C. coli* varied within the range of 10--20% without significant reduction ([@B23]). In contrast to EU, macrolides (e.g., tylosin) in USA had been approved for usage in food-producing animals as growth promoter for decades. Macrolide resistance in *C. coli* isolated from poultry, although higher than that in *C. jejuni*, has no significant change (5--20%) between 2002 and 2010.

Use of enrofloxacin in poultry was withdrawn by US-FDA in 2005 because it was supposed to induce fluoroquinolone resistance in *Campylobacter* and *Salmonella* from poultry and contribute to the antibiotic treatment failure in humans \[[@B36], [@B37]; [@B94]\]. After withdrawal of enrofloxacin from poultry, the rate of fluoroquinolone resistance in *Campylobacter* and *Salmonella* had been reduced in chicken during 2005--2007 ([@B93]). Human clinicians also observed a reduction in domestically acquired *Campylobacter* and *Salmonella* infections with decreased susceptibility to fluoroquinolones, and it was thought to be a great achievement regarding public health ([@B94]). However, the incidence rate of fluoroquinolone-resistant *C. jejuni*, from chicken breast, again increased (15.2\~22.5%) in 2008--2010. Similarly, fluoroquinolone-resistant *Campylobacter* from broilers was also raised from 5.3 to 8.6% and from 0.8 to 7.7% in Denmark and Japan, respectively ([@B14]; [@B70]; [@B23]; [@B93]).

CONCLUSION AND PERSPECTIVES
---------------------------

Definite targeting of pathogens, well-known mechanisms of activity, and preferable stability for administration are the unique advantages of antimicrobial use in food-animals for the prevention and treatment of bacterial and parasitic diseases, improvement of animal production performance, and protection of environment and public health. Withdrawal of antimicrobial use from food-producing animals may bring adverse effects on the production of food derived from animals and thus, on public health. EU banned only low-dose antibiotics (5\~40 ppm) for their use as growth promoters in food animals. Until now, without helping for the cause, it led to some negative effects on food animal production and public health. What will happen if the antimicrobial agents are banned worldwide, especially in some developing countries with rapid increase in human population and food demand?

As a double-edged sword, non-rational uses of veterinary antimicrobials may result in pressure selection of antimicrobial resistant pathogens which may endanger both the animal and public health. Additionally, the presence of antibiotic residues in the environment, associated with overuse of antimicrobial drugs, may adversely influence the manure treatment systems by inhibition of biogas production. An economic analysis about use and withdrawal of antimicrobial growth promoters in USA revealed that the withdrawal may cause increased cost (\$10/person) for food consumption and antibiotic-resistant infections cost the US healthcare system an excess of \$20 billion (\$60/person) annually ([@B9]). However, it is unknown that how much of these \$20 billion is due to antimicrobial resistance associated with their use in food-producing animals.

Recently, the US FDA has also proposed restrictions on the antimicrobial growth promoters because some available information and evidences suggested that the sub-therapeutic use may increase the risk of antimicrobial resistance. To make wise strategies for controlling antimicrobial resistance and effectively respond to the public health concerns associated with drug resistance, FDA believes that it is very important and imperative to consider how antimicrobial drugs are being used and how to address their injudicious uses in nature. Only rational use and effective regulation can ensure a benefit--risk balance of the antimicrobial application in animal production. However, long-term policies will be required for the international regulation of antibiotic use in food-producing animals.
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